Boehringer Ingelheim Corporation Selects Certara Corporation's D360 as its Global Drug Discovery Platform
Published: Oct 17, 2013
ST. LOUIS--(BUSINESS WIRE)--Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that the pharmaceutical company Boehringer Ingelheim has chosen D360 as its global drug discovery platform. Certara’s D360 is an integrated solution for the query, analysis and visualization of drug discovery and development data. D360 will allow Boehringer Ingelheim to share discovery data across global working groups that can include external collaborators.
Help employers find you! Check out all the jobs and post your resume.